Ontology highlight
ABSTRACT:
SUBMITTER: Deng C
PROVIDER: S-EPMC5399186 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature
Deng C C Zhang B B Zhang S S Duan C C Cao Y Y Kang W W Yan H H Ding X X Zhou F F Wu L L Duan G G Shen S S Xu G G Zhang W W Chen M M Huang S S Zhang X X Lv Y Y Ling T T Wang L L Zou X X
Cell death & disease 20160218
Cucurbitacin-I (Cu-I, also known as Elatericin B or JSI-124) is developed to inhibit constitutive and abnormal activation of STAT3 in many cancers, demonstrating a potent anticancer activity by targeting disruption of STAT3 function. Here, we for the first time systematically studied the underlying molecular mechanisms of Cu-I-induced gastric cancer cell death both in vitro and in vivo. In our study, we show that Cu-I markedly inhibits gastric cancer cell growth by inducing G2/M phase cell cycle ...[more]